Clinical pharmacology of the hypocholesterolemic agent K 12.148 (lifibrol) in healthy volunteers
- 1 January 1991
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 40 (1) , S91-S94
- https://doi.org/10.1007/bf01409417
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- LovastatinDrugs, 1988
- An Overview of Lipid-Lowering DrugsDrugs, 1988
- Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsArchives of internal medicine (1960), 1988
- Analysis of plasma lipoproteins by ultracentrifugation in a new fixed angle rotor: Evaluation of a phosphotungstic acid/MgCl2 precipitation and a quantitative lipoprotein electrophoresis assayClinica Chimica Acta; International Journal of Clinical Chemistry, 1986
- Comparative efficacy of once versus twice daily mevinolin in the therapy of familial hypercholesterolemiaClinical Pharmacology & Therapeutics, 1986
- The Effect of CS-514, an Inhibitor of HMG-CoA Reductase, on Serum Lipids in Healthy VolunteersAtherosclerosis, 1986
- Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers.Journal of Clinical Investigation, 1982
- Rapid and substantial lowering of human serum cholesterol by mevinolin (MK-803), an inhibitor of hydroxymethylglutaryl-coenzyme a reductaseAtherosclerosis, 1982
- Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart DiseaseAnnals of Internal Medicine, 1971